AMBELVIST

View On IC.GC.CA

APPROVED

on 12 Feb 2025

Last Applicant/ Owned by

Bayer Intellectual Property GmbH

Alfred-Nobel-Str. 5040789 Monheim am Rhein

Serial Number

2220052 filed on 19^th Oct 2022

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

K1P1C3

AMBELVIST

Trademark usage description

contrast media for use in medical imaging

Classification Information

2220052

Trademark

Action Taken	Status
Submitted for opposition 22 on 23^rd Feb 2024	Search Recorded
Submitted for opposition 20 on 23^rd Feb 2024	Examiner's First Report
Submitted for opposition 223 on 23^rd Feb 2024	Total Provisional Refusal
Submitted for opposition 80 on 30^th Nov 2023	Change of Title Registered
Submitted for opposition 256 on 5^th Sept 2023	Notification of Possible Opposition Sent
Submitted for opposition 257 on 3^rd Nov 2022	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 3^rd Nov 2022	Created
Submitted for opposition 31 on 3^rd Nov 2022	Formalized
Submitted for opposition 30 on 19^th Oct 2022	Filed
Submitted for opposition 228 on 25^th Aug 2022	International Registration